Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
150 participants
OBSERVATIONAL
2017-09-01
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MicroRNAs in Renal Recovery - Pilot Study
NCT04381156
Acute Kidney Injury Following Paediatric Cardiac Surgery
NCT02289040
Noncoding RNAs in COVID-19 and COVID-19 Related Kidney Dysfunction
NCT04381351
Circulating lncRNA and CV Morbidities in CKD and ESRD
NCT02304471
An Observational Case Control Study to Identify the Role of MV and MV Derived Micro-RNA in Post CArdiac Surgery AKI
NCT02315183
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
observation of microRNA expression
no intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* inclusion in another study
* pregnancy
* Kidney transplantation in history
* GFR \< 30 ml/min (glomerular filtration rate)
* ECLS therapy (extracorporal life support)
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Heinrich-Heine University, Duesseldorf
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Klinik für Anästhesiologie
PD Dr. Timo Brandenburger
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Timo Brandenburger, M.D.
Role: PRINCIPAL_INVESTIGATOR
Klinik für Anästhesiologie, Heinrich-Heine-Universität Düsseldorf
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Klinik für Anästhesiologie
Düsseldorf, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017024132
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.